CAMPBELL HY: Open Payments
NPI 1902405798 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 10 payments from 7 companies in 2025. Trend: 2023 $464 · 2024 $1,919 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 3 | $287 |
| ARRAY BIOPHARMA INC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Janssen Biotech, Inc. | 1 | $28 |
| Stryker Corporation | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: MYRISK, BRAFTOVI, LIBTAYO, CARVYKTI, MOLLI, MONJUVI, KISQALI.
Industry payments across TX — which companies pay providers there.
